Article Listing - China gains WHO designation for biological products center

YUGOSLAV VACCINE PROGRAM

13 April 1992

ICN Pharmaceuticals of California and ICN-Galenika are to partly finance a project costing over $100,000 to vaccinate children in the...

SCHERING CORP TO MARKET FELBAMATE

13 April 1992

Schering Corp reports that it will have exclusive rights to market Carter-Wallace's N-methyl-D-aspartate receptor antagonist anticonvulsant felbamate worldwide, with the...

URIACH BUILDS NEW PLANT

13 April 1992

The Spanish pharmaceutical comp-any, Uriach, is constructing a new plant, reports the Spanish magazine Siete Dias Medicos.

The work is...

INTERNATIONAL INDUSTRY DISCUSSES JAPAN

13 April 1992

Representatives of the Japan Pharmaceutical Manufacturers Association, the European Busi-ness Council and the US Pharmaceutical Manufacturers Association met in Palm...

EARLY FIGURES SHOW GOOD UK PHARMA TRADE BALANCE

13 April 1992

For January of this year, the UK pharmaceutical industry reported a massive 66% increase in trade with the rest of...

1991 A "SUPERB" YEAR FOR MARION MERRELL DOW

13 April 1992

Us pharmaceutical concern Marion Merrell Dow's second full year since its formation was a superb year financially, according to its...

CANGUARD CLEARED OF CONTEMPT

13 April 1992

The Canadian company Canguard Health Technologies has been cleared of contempt of court charges brought by Deprenyl Research Ltd regarding...

OPTIMISTIC ANALYSIS OF WARNER-LAMBERT

13 April 1992

Despite the not so positive general consensus opinion on Warner-Lambert, analyst Jonathan Gelles at Wertheim Schroder is recommending purchase of...

NEW GENERAL COUNSEL AT IDEC

13 April 1992

At IDEC Pharmaceuticals Corp, Kenneth Woolcott has been promoted to general counsel.

SCHWARZ PHARMA MAKES STRIDES IN EAST GERMANY

13 April 1992

The medium-sized German drugmaker Schwarz Pharma AG has criticized the 25% discount regulation applying to eastern German drugs sales. Board...

Showing 94511-94520 of 95569 articles

Go to beginningPreviousNextGo to end